SBIR/STTR Research Award

Mycotoxin Adsorption with Hemocompatible Porous Polymer Beads

Award identifier 82af0c11fe83ea193b38cf65b6da807aa88096e0f1dd12beb38c642cb935012bAwarding agency Department of Defense · Office for Chemical and Biological Defense

Award amount

$999,997

Program and phase

SBIR · Phase II

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Office for Chemical and Biological Defense
Recipient company
CYTOSORBENTS MEDICAL INC
Proposal award date
2017-02-01
Contract end date
2019-01-31
UEI
LSF2KFUSY4K7
Solicitation number
2015.2
Topic code
CBD152-003

Research abstract

Certain species of fungi produce mycotoxins, which can cause acute toxicity and even death in human that either have been, or potentiallycould be, used by bioterroists as weapons of mass destruction. Aflatoxin and trichothecene T-2 toxin are two mycotoxins that are of particularconcern as potential biological weapons due to their toxicity, environmental stability, easy accessibility, historical production for use inbiowarfare and lack of specific therapy. We propose applying our broad spectrum hemoadsorbent CytoSorb as a medical countermeasure. Wehypothesize that hemoadsorption will have a significant impact on survival by directly reducing the toxin level as well as reducing the levels ofdamage-associated molecules released into circulation. During the Phase I, we demonstrated the ability of CytoSorb to efficiently remove>99% of the aflatoxin and T-2 toxin from whole blood in vitro. For Phase II we propose in vivo studies to demonstrate the efficacy our polymerin reducing systemic toxicity caused by mycotoxins. Further we proposed advancing the development of our hemoadsorption device to meetmilitary supply logistics. The outcome will be the demonstration of a safe and effective method for removal of aflatoxin and T-2 toxin fromblood, a currently unaddressed area of relevance for biowarfare defense.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

16 SBIR/STTR records share this UEI (2012–2023). Reported award amounts total $11,830,667. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, Department of Health and Human Services

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.